KXA
AUGX

KPCB XV Associates’s Augmedix, Inc. Common Stock AUGX Stock Holding History

KPCB XV Associates’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-708
Closed -$1K – 4
2022
Q2 		$1K Hold
708
– – ﹤0.01% 4
2022
Q1 		$2K Buy
+708
New +$1.92K ﹤0.01% 4

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DIV
DCM International VI Menlo Park, California $114M AUM 73.96% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KPCB XV Associates's AUGX Position: Q3 2022 in Review

KPCB XV Associates sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2022, closing a stake of 708 shares — an estimated $1K sold.

KPCB XV Associates first reported a position in AUGX in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 28 funds tracked by Wall St. Rank hold AUGX as of Q3 2022.

  • KPCB XV Associates reported no remaining Augmedix, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • KPCB XV Associates sold 708 Augmedix, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • KPCB XV Associates first reported a position in Augmedix, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • KPCB XV Associates's Augmedix, Inc. Common Stock position peaked at $2K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2022.

Based on KPCB XV Associates's 13F filing for Q3 2022, filed 26 Oct 2022.